Dennis Hapke

In 2011, Dennis Hapke began their professional career with a role as an Auszubildender zum Industriekaufmann at Solvay. Dennis then moved on to work as a Clerk Finance & Controlling at Abbott from June 2013 to January 2015. Following this, they joined Mylan in February 2015 as a Junior-Controller, and later became a Financial Planning Analysis Manager from January 2016 to May 2019. In June 2019, Hapke joined Johnson & Johnson as a Portfolio Specialist, and later became a Product Manager Biosurgery & Portfolio Specialist from June 2020 to November 2022. Currently, they are working at Neuraxpharm as the CNS Business Unit Lead starting from December 2022.

Dennis Hapke completed their Bachelor of Arts degree in Unternehmensführung & Entrepreneurship from FHWien der WKW in 2019. Dennis is currently pursuing a Master's degree in Management at IMC Krems University of Applied Sciences, expected to be completed in 2024.